Please assess the completion status of the following clinical trial:

Trial Title: A Trial to Study the Influence of Growth Factors on Bone Marrow and Hepatic Regeneration in Patients With Decompensated Cirrhosis.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects aged 18-65 years~* All patients who are known to have cirrhosis of liver with portal hypertension and are compensated on presentation with no features of ascites/ jaundice/ bleed/ HE/ HRS.~* Only patients with alcoholic cirrhosis and cryptogenic cirrhosis (etiology work up negative) will be enrolled in the study.~Exclusion Criteria:~* Sepsis ( Any culture positive: blood, urine, any other obvious source of infection: UTI, LRTI)~* Variceal bleed in the past 3 months~* Autoimmune disorders~* HCC (Hepatocellular Carcinoma)~* Multi organ failure~* Any features of decompensation in form of ascites/Jaundice/ HE (grade 3 or 4) / HRS~* HIV seropositivity~* Essential hypertension~* Pregnancy~* Refusal to participate in the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- G-CSF + Erythropoietin (Type: EXPERIMENTAL): None
- G-CSF (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).